13 May 2023 in PharmacoEconomics - Open
Background The resources for critical care are limited in many settings, exacerbating the significant morbidity and mortality associated with critical illness. Budget constraints can lead to choices between investing in advanced critical care (e.g. mechanical ventilators in intensive care units) or more basic critical care such as Essential Emergency and Critical Care (EECC; e.g. vital signs monitoring, oxygen therapy, and intravenous fluids). Methods We investigated the cost effectiveness of providing EECC and advanced critical care in Tanzania in comparison with providing ‘no critical care’ or ‘district hospital-level critical care’ using coronavirus disease 2019 (COVID-19) as a tracer condition. We developed an open-source Markov model (https://github.com/EECCnetwork/POETIC_CEA) to estimate costs and disability-adjusted life-years (DALYs) averted, using a provider perspective, a 28-day time horizon, patient outcomes obtained from an elicitation method involving a seven-member expert group, a normative costing study, and published literature. We performed a univariate and probabilistic sensitivity analysis to assess the robustness of our results., Results EECC is cost effective 94% and 99% of the time when compared with no critical care (incremental cost-effectiveness ratio [ICER] $37 [−$9 to $790] per DALY averted) and district hospital-level critical care (ICER $14 [−$200 to $263] per DALY averted), respectively, relative to the lowest identified estimate of the willingness-to-pay threshold for Tanzania ($101 per DALY averted). Advanced critical care is cost effective 27% and 40% of the time, when compared with the no critical care or district hospital-level critical care scenarios, respectively. Conclusion For settings where there is limited or no critical care delivery, implementation of EECC could be a highly cost-effective investment. It could reduce mortality and morbidity for critically ill COVID-19 patients, and its cost effectiveness falls within the range considered ‘highly cost effective’. Further research is needed to explore the potential of EECC to generate even greater benefits and value for money when patients with diagnoses other than COVID-19 are accounted for.
1 December 2017 in Journal of Critical Care
9 October 2026 in SSRN Electronic Journal
Introduction: Critical illness is a leading cause of mortality worldwide with the highest burden in low- and middle-income countries. Essential Emergency and Critical Care (EECC) is the foundational, low-cost care needed by all critically ill patients that is feasible to deliver in all health facilities globally. Unfortunately, EECC is often not provided. This study aimed to assess the determinants of non-provision of EECC in primary health care in the United Republic of Tanzania to inform a national EECC scale-up program.Methods: A convergent mixed-methods assessment was conducted in 24 purposively selected health facilities in five regions of mainland Tanzania and Zanzibar. Quantitative resource-readiness and clinical-process assessments were combined with 24 individual interviews and six focus group discussions, and converged using the capability, opportunity, motivation, behavior construct in the Consolidated Framework for Implementation Research: Findings Only 27%-34% of critically ill patients received EECC. Nine determinants of non-provision emerged: gaps in knowledge and skills; inefficient use of staff time; misperceived roles of lower-level facilities; emphasis on advanced care without EECC; poor availability and distribution of resources; oxygen not in place or in use; service organization barriers; low motivation and disincentives to care for the critically ill; and vertical programs determine managers’ priorities.Interpretation: Non-provision of EECC is not primarily an individual failing, but reflects how the foundational care of critical illness is poorly supported and prioritized within the health system, through a self-reinforcing cycle of limited knowledge, weak readiness and system-level acceptance. Strengthening care to reduce preventable mortality necessitates a targeting of context-specific determinants, and an embedding of EECC into health systems and patient management at all levels of health facilities.